stella
beta
Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma — Stella
Recruiting
Back to Adenocarcinoma Esophagus trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio
View full record on ClinicalTrials.gov